Onmark Regimen Profiler® Enhanced with New Customization and Reporting Capabilities

Onmark Regimen Profiler is a Web-based resource introduced in 2006 that helps community-based practices and their patients understand clinical and financial information about treatment regimens for a range of disease states requiring therapy with specialty drugs including cancer, rheumatoid arthritis and osteoporosis. Over 400 referenced treatment regimens are included in Onmark Regimen Profiler's extensive clinical library.

The enhancements include:

• Ability to complete a more detailed analysis of financial information for different treatment regimens. For example, Onmark Regimen Profiler now allows users to calculate non-drug costs at the Current Procedural Terminology (CPT) level for E&M, administration and lab test procedures, rather than setting a flat treatment rate.
• Ability to customize downloadable financial reports to more accurately reflect the way the practice actually administers therapy. Users can adjust reporting fields including the number of treatment cycles, cycle length, drug dosing, and patient body surface area (BSA).
• Ability to customize regimens for a specific patient. Users can override a default patient weight used for “per kg” dosing by using a BSA calculator to set a specific patient weight, which will then be used to calculate the “per kg” dosing.
• Easier identification of regimens that have been added or changed in the tool over the past two months, allowing users to quickly access the latest clinical updates and pull current reports.

Frank discussions between providers and patients about the cost of treatment before it is initiated is becoming increasingly important. The tool's Patient Profiler feature facilitates these conversations by reporting a patient's anticipated financial responsibility in easy-to-read reports that can now be customized to include the practice name, logo and phone number.

“The enhancements to Onmark Regimen Profiler expand the information that practices and patients can review before initiating therapy,” said Mike Cunningham, PharmD, vice president and general manager of Onmark. “With over 450 practices now using Regimen Profiler on a regular basis, we will continue investing in enhancements to this tool that meet the evolving needs of our membership.

The next phase of enhancements for Onmark Regimen Profiler will focus on providing detailed information on FDA and compendia approval status, which practices may reference when submitting requests for reimbursement.

“Onmark Regimen Profiler will soon contain FDA and compendia approval status of a regimen utilized for a specific diagnosis, which is particularly relevant given recently added compendiums and subsequent confusion in the market about drugs' approval status” said Kim Bergstrom, Pharm D, chief clinical officer, McKesson Specialty Care Solutions. “Onmark Regimen Profiler aims to provide actionable, time-saving information that empower practices to be knowledgeable and up to date about whether a regimen they recommend to a patient will be reimbursed by CMS and other payors.”

Onmark members can access Onmark Regimen Profiler free of charge via the Practice Management tab of www.onmarkservices.com. Recent webcasts detailing the new functionality are also available for replay under the Past Events section of the website.

About Onmark
Onmark, a McKesson Specialty Care Solutions company, is a leading national group purchasing organization (GPO) for community-based practices with more than 3,000 members representing over 4,800 physicians and in excess of $8 billion in annual drug purchases. Through strategic relationships with McKesson Corporation, pharmaceutical companies and industry experts, Onmark provides its members with access to a full portfolio of competitive contracts for pharmaceutical products and medical/surgical supplies, the most aggressive pricing available through McKesson, practice management resources, clinical tools and educational programs. For information about the products, services and programs available to Onmark members, visit www.onmarkservices.com.

About McKesson and McKesson Specialty Care Solutions
McKesson Corporation, currently ranked 18th on the FORTUNE 500, is a healthcare services and healthcare information technology company dedicated to helping its customers deliver high-quality healthcare by reducing costs, streamlining processes, and improving the quality and safety of patient care. McKesson is the longest-operating company in healthcare today, marking its 175th anniversary last year. Over the course of its history, McKesson has grown by providing pharmaceutical and medical-surgical supply management across the spectrum of care; healthcare information technology for hospitals, physicians, homecare and payors; hospital and retail pharmacy automation; and services for manufacturers and payors designed to improve outcomes for patients. A business unit of McKesson Corporation, McKesson Specialty Care Solutions including Onmark delivers the services manufacturers, payors and providers need to ensure specialty pharmaceutical products, coordinated reimbursement and clinical services are available to patients with complex diseases. For more information, visit www.mckesson.com.

Contact
Toni Eberhardt
480-663-4108
toni.eberhardt@mckesson.com

PR Contact

Toni Eberhardt 480-663-4108 toni.eberhardt@mckesson.com